US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema

被引:215
作者
Busse, Paula J. [1 ]
Christiansen, Sandra C. [2 ]
Riedl, Marc A. [2 ]
Banerji, Aleena [3 ]
Bernstein, Jonathan A. [4 ]
Castaldo, Anthony J. [5 ]
Craig, Timothy [6 ]
Davis-Lorton, Mark [7 ]
Frank, Michael M. [8 ]
Li, H. Henry [9 ]
Lumry, William R. [10 ]
Zuraw, Bruce L. [2 ,11 ]
机构
[1] Mt Sinai Sch Med, Dept Med, Div Rheumatol Allergy & Immunol, New York, NY USA
[2] Univ Calif San Diego, Dept Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[3] Harvard Med Sch, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[4] Univ Cincinnati, Coll Med, Dept Med, Div Immunol Rheumatol & Allergy, Cincinnati, OH USA
[5] US Hereditary Angioedema Assoc, Fairfax, VA USA
[6] Penn State Univ, Dept Med Pediat & Grad Studies, Div Allergy Asthma & Immunol, Hershey, PA USA
[7] NYU Winthrop Hosp, Dept Med, Div Rheumatol Allergy & Clin Immunol, Mineola, NY USA
[8] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[9] Inst Asthma & Allergy, Med Serv, Chevy Chase, MD USA
[10] Allergy & Asthma Res Associates Res Ctr, Dallas, TX USA
[11] San Diego Vet Adm Healthcare, San Diego, CA USA
关键词
Hereditary angioedema; C1; inhibitor; Bradykinin; Management; On-demand treatment; Prophylactic treatment; QUALITY-OF-LIFE; C1 INHIBITOR DEFICIENCY; SHORT-TERM PROPHYLAXIS; FACTOR-XII MUTATION; C1-INHIBITOR CONCENTRATE; ESTERASE INHIBITOR; ACUTE ATTACKS; C1-ESTERASE INHIBITOR; ANGIONEUROTIC-EDEMA; DOUBLE-BLIND;
D O I
10.1016/j.jaip.2020.08.046
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Scientific and clinical progress together with the development of effective novel therapeutic options has engendered multiple important changes in the diagnosis and management of hereditary angioedema (HAE). We now update and extend the 2013 United States Hereditary Angioedema Association Medical Advisory Board guidelines for the treatment and management of HAE. The guidelines are based on a comprehensive literature review with recommendations indicating both the strength of our recommendation and the quality of the underlying evidence. Guidelines are provided regarding the classification, diagnosis, on-demand treatment, prophylactic treatment, special considerations for women and children, development of a comprehensive management and monitoring plan, and assessment of burden of illness for both HAE due to C1 inhibitor deficiency and HAE with normal C1 inhibitor. Advances in HAE treatment now allow the development of management plans that can help many patients with HAE lead a normal life. Achieving this goal requires that physicians be familiar with the diagnostic and therapeutic transformations that have occurred in recent years. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:132 / 150.e3
页数:22
相关论文
共 175 条
[1]   Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond [J].
Agostoni, Angelo ;
Aygoeren-Puersuen, Emel ;
Binkley, Karen E. ;
Blanch, Alvaro ;
Bork, Konrad ;
Bouillet, Laurence ;
Bucher, Christoph ;
Castaldo, Anthony J. ;
Cicardi, Marco ;
Davis, Alvin E., III ;
De Carolis, Caterina ;
Drouet, Christian ;
Duponchel, Christiane ;
Farkas, Henriette ;
Fay, Kalman ;
Fekete, Bela ;
Fischer, Bettina ;
Fontana, Luigi ;
Fuest, George ;
Giacomelli, Roberto ;
Groener, Albrecht ;
Hack, C. Erik ;
Harmat, George ;
Jakenfelds, John ;
Juers, Mathias ;
Kalmar, Lajos ;
Kaposi, Pal N. ;
Karadi, Istvan ;
Kitzinger, Arianna ;
Kollar, Timea ;
Kreuz, Wolfhart ;
Lakatos, Peter ;
Longhurst, Hilary J. ;
Lopez-Trascasa, Margarita ;
Martinez-Saguer, Inmaculada ;
Monnier, Nicole ;
Nagy, Istvan ;
Nemeth, Eva ;
Nielsen, Erik Waage ;
Nuijens, Jan H. ;
O'Grady, Caroline ;
Pappalardo, Emanuela ;
Penna, Vincenzo ;
Perricone, Carlo ;
Perricone, Roberto ;
Rauch, Ursula ;
Roche, Olga ;
Rusicke, Eva ;
Spaeth, Peter J. ;
Szendei, George .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :S51-S131
[2]   Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency [J].
Andrasi, Noemi ;
Veszeli, Nora ;
Holdonner, Agnes ;
Temesszentandrasi, Gyorgy ;
Kohalmi, Kinga Viktoria ;
Varga, Lilian ;
Farkas, Henriette .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
[3]   GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength [J].
Andrews, Jeffrey C. ;
Schuenemann, Holger J. ;
Oxman, Andrew D. ;
Pottie, Kevin ;
Meerpohl, Joerg J. ;
Coello, Pablo Alonso ;
Rind, David ;
Montori, Victor M. ;
Brito, Juan Pablo ;
Norris, Susan ;
Elbarbary, Mahmoud ;
Post, Piet ;
Nasser, Mona ;
Shukla, Vijay ;
Jaeschke, Roman ;
Brozek, Jan ;
Djulbegovic, Ben ;
Guyatt, Gordon .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (07) :726-735
[4]   Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema [J].
Aygoeren-Puersuen, E. ;
Bygum, A. ;
Grivcheva-Panovska, V. ;
Magerl, M. ;
Graff, J. ;
Steiner, U. C. ;
Fain, O. ;
Huissoon, A. ;
Kinaciyan, T. ;
Farkas, H. ;
Lleonart, R. ;
Longhurst, H. J. ;
Rae, W. ;
Triggiani, M. ;
Aberer, W. ;
Cancian, M. ;
Zanichelli, A. ;
Smith, W. B. ;
Baeza, M. L. ;
Du-Thanh, A. ;
Gompels, M. ;
Gonzalez-Quevedo, T. ;
Greve, J. ;
Guilarte, M. ;
Katelaris, C. ;
Dobo, S. ;
Cornpropst, M. ;
Clemons, D. ;
Fang, L. ;
Collis, P. ;
Sheridan, W. ;
Maurer, M. ;
Cicardi, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04) :352-362
[5]   Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings [J].
Aygoeren-Puersuen, Emel ;
Soteres, Daniel ;
Moldovan, Dumitru ;
Christensen, Jim ;
Van Leerberghe, Arthur ;
Hao, James ;
Schranz, Jennifer ;
Jacobson, Kraig W. ;
Martinez-Saguer, Inmaculada .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2017, 173 (02) :114-119
[6]   Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe [J].
Aygoeren-Puersuen, Emel ;
Bygum, Anette ;
Beusterien, Kathleen ;
Hautamaki, Emily ;
Sisic, Zlatko ;
Wait, Suzanne ;
Boysen, Henrik B. ;
Caballero, Teresa .
ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
[7]   Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema [J].
Bafunno, Valeria ;
Firinu, Davide ;
D'Apolito, Maria ;
Cordisco, Giorgia ;
Loffredo, Stefania ;
Leccese, Angelica ;
Bova, Maria ;
Barca, Maria Pina ;
Santacroce, Rosa ;
Cicardi, Marco ;
Del Giacco, Stefano ;
Margaglione, Maurizio .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (03) :1009-1017
[8]   Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks A Randomized Clinical Trial [J].
Banerji, Aleena ;
Riedl, Marc A. ;
Bernstein, Jonathan A. ;
Cicardi, Marco ;
Longhurst, Hilary J. ;
Zuraw, Bruce L. ;
Busse, Paula J. ;
Anderson, John ;
Magerl, Markus ;
Martinez-Saguer, Inmaculada ;
Davis-Lorton, Mark ;
Zanichelli, Andrea ;
Li, H. Henry ;
Craig, Timothy ;
Jacobs, Joshua ;
Johnston, Douglas T. ;
Shapiro, Ralph ;
Yang, William H. ;
Lumry, William R. ;
Manning, Michael E. ;
Schwartz, Lawrence B. ;
Shennak, Mustafa ;
Soteres, Daniel ;
Zaragoza-Urdaz, Rafael H. ;
Gierer, Selina ;
Smith, Andrew M. ;
Tachdjian, Raffi ;
JamesWedner, H. ;
Hebert, Jacques ;
Rehman, Syed M. ;
Staubach, Petra ;
Schranz, Jennifer ;
Baptista, Jovanna ;
Nothaft, Wolfram ;
Maurer, Marcus .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (20) :2108-2121
[9]   Hereditary angioedema from the patient's perspective: A follow-up patient survey [J].
Banerji, Aleena ;
Li, Yu ;
Busse, Paula ;
Riedl, Marc A. ;
Holtzman, Nicole S. ;
Li, Huamin Henry ;
Davis-Lorton, Mark ;
Bernstein, Jonathan A. ;
Frank, Michael ;
Castaldo, Anthony J. ;
Long, Janet ;
Zuraw, Bruce ;
Lumry, William ;
Christiansen, Sandra .
ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (03) :212-223
[10]   Managing the female patient with hereditary angioedema [J].
Banerji, Aleena ;
Riedl, Marc .
WOMENS HEALTH, 2016, 12 (03) :351-361